✦ LIBER ✦

Outcomes and quality of care in acute myeloid leukemia over 40 years

✍ Scribed by Shabbir M. H. Alibhai; Marc Leach; Mark D. Minden; Joseph Brandwein

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 216 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24373

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of weekend admissions on quality

Impact of weekend admissions on quality of care and outcomes in patients with acute myeloid leukemia

✍ Nelli Bejanyan; Alex Z. Fu; Aleksandr Lazaryan; Rao Fu; Matt Kalaycio; Anjali Ad 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB 👁 1 views

Prognostic factors and outcome of recurr

Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia

✍ Jeffrey E. Rubnitz; Bassem I. Razzouk; Shelly Lensing; Stanley Pounds; Ching-Hon 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

Relapse after autologous hematopoietic s

Relapse after autologous hematopoietic stem cell transplantation in acute myeloid leukemia, a single center experience over 13 years

✍ Vincent Lévy; Zora Marjanovic; Anne Vekhoff; Ramdam Belhocine; Jean Pierre Marie 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB 👁 2 views

Survival and predictors of outcome in pa

Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit

✍ Snehal G. Thakkar; Alex Z. Fu; John W. Sweetenham; Zachariah A. Mciver; Sanjay R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views

## Abstract ## BACKGROUND. Predictors of outcome and rates of successful discharge have not been defined for patients with acute leukemia admitted to intensive care units (ICUs) in the US. ## METHODS. This is a retrospective analysis of 90 patients with acute leukemia (no history of bone marrow

In vivo expression of survivin and its s

In vivo expression of survivin and its splice variant survivin-2B: Impact on clinical outcome in acute myeloid leukemia

✍ Mandy Wagner; Karin Schmelz; Christian Wuchter; Wolf-Dieter Ludwig; Bernd Dörken 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 229 KB 👁 1 views

## Abstract Survivin, a member of the inhibitor of apoptosis protein family, is expressed in most human cancers, but undetectable in normal differentiated adult tissue __in vivo__. Because of this cancer‐related expression, survivin is a promising target for cancer therapy. To determine the express

Results of intensive chemotherapy in 998

Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: : Predictive prognostic models for outcome

✍ Hagop Kantarjian; Susan O'Brien; Jorge Cortes; Francis Giles; Stefan Faderl; Eli 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

## Abstract ## BACKGROUND Elderly patients (age ≥ 65 years) with acute myeloid leukemia (AML) generally have a poor prognosis. AML‐type therapy results are often derived from studies in younger patients and may not apply to elderly AML. Many investigators and oncologists advocate, at times, only s